| Date | Title | Description | Source |
| 17.04.2024 | The Shrinking Series E: More Senior Startups Raise Smaller F... | 9 Shares Email Facebook Twitter LinkedIn
Typically, when a venture-backed startup raises a follow-on... | news.crunc... |
| 11.03.2024 | Most-Active US Investors: Andreessen Horowitz, GV And Alumni... | 10 Shares Email Facebook Twitter LinkedIn
This is a monthly feature that runs down some of the most ... | news.crunc... |
| 05.03.2024 | The 10 Biggest Rounds Of February: Epic Games Leads The List... | 6 Shares Email Facebook Twitter LinkedIn
This is a monthly feature that runs down the month’s top 10... | news.crunc... |
| 27.02.2024 | Freenome scores $254M to advance its cancer-detection blood ... | The San Francisco company readies to reveal its first clinical study results in the near term
When i... | vator.tv/n... |
| 20.02.2024 | Freenome's $254M Boost for Early Cancer Detection | Freenome, a biotech company in San Francisco, just secured a massive $254M in funding to advance the... | parsers.vc... |
| 15.02.2024 | Freenome Raises $254M to Accelerate Early Cancer Detection P... | What You Should Know:
– Freenome, a leader in blood-based early cancer detection, has raised $254M i... | hitconsult... |
| 15.02.2024 | Freenome Raises $254M in Funding | Freenome, a San Francisco, CA-based biotechnology company developing blood tests for early cancer de... | finsmes.co... |
| 15.02.2024 | Roche leads Freenome's $254M funding round for cancer-detect... | In early 2022, Freenome surpassed $1 billion in lifetime financing after raking in two nine-figure f... | fiercebiot... |
| 12.10.2023 | Bytes to Bites part three – Wellness wired: Leveraging AI to... | Editor’s Note: Eva Everloo is senior investment analyst and Dr. Anđela Martinović is scientific anal... | agfunderne... |
| 15.06.2023 | With CVS Health’s Exit, Walgreens Steps Up Clinical Research... | Walgreens further expanded its clinical trials and research business, partnering with biotech ... [+... | forbes.com... |
| 22.05.2023 | Freenome Acquires Oncimmune | Mike Nolan, CEO of Freenome
Freenome, a South San Francisco, CA-based biotech company, acquired Onci... | finsmes.co... |
| 16.12.2022 | A Silicon Valley biotech just showed a simple blood test can... | A standard blood draw. Hollis Johnson/Business Insider
Guardant Health said that its blood test to s... | businessin... |
| 21.10.2022 | Meet Vasudev Bailey, Senior Partner at ARTIS Ventures | ARTIS invests in what it calls the TechBio space, where technology meets healthcare
Venture capital ... | vator.tv/n... |
| 12.09.2022 | Freenome Launches Multi-Cancer Detection Study Pairing Multi... | What You Should Know:
Freenome is a biotechnology company with a comprehensive multiomics platform f... | hitconsult... |
| 12.01.2022 | Citadel Securities forms an unlikely partnership for its nex... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 11.01.2022 | Freenome raises $290M from Roche | Freenome said today that it has raised $290 million from Roche to advance its cancer early detection... | massdevice... |
| 10.01.2022 | New Year, New Fund, New Opportunities in Bio + Health | 2021 saw higher than ever funding of startups, continued maturation of the tech-enabled bio and heal... | a16z.com/2... |
| 07.12.2021 | Freenome one-ups itself with $300M from GV, Roche and more t... | In what has become a near-annual tradition for Freenome, the developer of a liquid biopsy platform f... | fiercebiot... |
| 07.12.2021 | Freenome one-ups itself with $300M from GV, Roche and more t... | In what has become a near-annual tradition for Freenome, the developer of a liquid biopsy platform f... | fiercebiot... |
| 21.05.2021 | Freenome, high-profile liquid biopsy company, quietly replac... | Freenome, a high-profile startup that aims to develop a blood test to detect colon cancer, has quiet... | statnews.c... |
| 26.08.2020 | Freenome Secures $270M Series C To Research Cancer-Detecting... | 7 Shares Email Facebook Twitter LinkedIn
Biotechnology company Freenome announced its largest fundin... | news.crunc... |
| 26.08.2020 | Riding on early cancer detection frenzy, Freenome scor... | Covid-19 and its manifold secondary effects have forced many biotech companies to adapt their ... | endpts.com... |
| 26.08.2020 | Freenome Closes $270M Series C Financing | Freenome, a South San Francisco, Calif.-based biotechnology company, raised $270m in Series C financ... | finsmes.co... |
| 11.11.2019 | Investors just poured more than $1 billion into startups usi... | Dr. Ali Parsa, the CEO of Babylon Health. Jack Lewis Williams for Tailor Made London This story is a... | businessin... |
| 09.10.2019 | Andreessen Horowitz hires Julie Yoo as general partner | Julie Yoo has joined Andreessen Horowitz as its newest general partner. She will make investments ou... | techcrunch... |
| 26.08.2019 | ADC Therapeutics signs pact with Freenome; Shanghai Hen... | → ADC Therapeutics, which last month closed its monster $303 million E round, is joining force... | endpts.com... |
| 01.08.2019 | Freenome: This Multiomics Blood Testing Platform Raised $160... | Freenome — a biotechnology company that pioneered a multiomics platform for early cancer detection —... | pulse2.com... |
| 24.07.2019 | With $160 million in new funding, Freenome looks to commerci... | One of the major problems that technology companies working to find a cure for cancer need to solve ... | techcrunch... |
| 24.07.2019 | Freenome nabs $160M to advance blood-based colorectal cancer... | Other new investors in the round include Roche Venture Fund, Kaiser Permanente Ventures and the soci... | medcitynew... |
| 24.07.2019 | Freenome Raises $160M in Series B Financing | Freenome, a South San Francisco, Calif.-based biotechnology company that has developed a multiomics ... | finsmes.co... |
| 16.04.2019 | Guardant Health study shows liquid biopsy picking up more mu... | Based on interviews with oncologists, Cannacord analyst Mark Massaro wrote in a note to clients Tues... | medcitynew... |
| 24.01.2019 | Alphabet’s healthcare subsidiary Verily is expanding its sta... | Verily Life Sciences, the healthcare subsidiary of Google’s parent company, Alphabet, is expanding t... | techcrunch... |
| 15.05.2018 | With new $600M fund, CRV expands into bioengineering investm... | In addition to bioengineering, Fund XVII will also invest in enterprise, consumer-centered companies... | medcitynew... |
| 14.12.2017 | Andreessen Horowitz has a new, $450 million bio fund | Almost exactly two years ago, the venture firm Andreessen Horowitz took the wraps off a $200 million... | techcrunch... |
| 29.08.2017 | Term Sheet — Tuesday, August 29 | THREE THINGS
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundari... | fortune.co... |
| 28.08.2017 | Freenome Raises Additional $7m in Series A Funding | Freenome, a South San Francisco, CA-based health technology company innovating disease management th... | finsmes.co... |
| 06.07.2017 | Report: Alphabet venture arm GV, Khosla Ventures claim top s... | Two investors that embrace this hybrid approach to healthcare investment also topped the category fo... | medcitynew... |
| 21.06.2017 | Andreessen Horowitz gets a new general partner in Jorge Cond... | Andreessen Horowitz is making an even bigger push into healthcare IT, bringing aboard serial entrepr... | techcrunch... |
| 12.05.2017 | Guardant Health adds $360 million to its war chest | Guardant Health, a four-year-old, Redwood City, Ca.-based biotech company that sells blood tests to ... | techcrunch... |
| 16.03.2017 | Advances in AI and ML are reshaping healthcare | Megh Gupta Contributor
Megh Gupta is a member of the investment team at OMERS Ventures.
Qasim Mohamm... | techcrunch... |
| 02.03.2017 | Term Sheet — Thursday, March 2 | BIG FOOD + SNAP
Good morning, Term Sheet readers. Today’s guest column is a doubleheader: In part on... | fortune.co... |
| 01.03.2017 | In liquid biopsy race, Freenome lands $65 million, led by An... | Freenome, a two-year-old liquid biopsy diagnosis platform that detects the cell-free DNA sequencing ... | techcrunch... |
| 01.03.2017 | GV Joins $65M Series A for Freenome | SAN FRANCISCO--(BUSINESS WIRE)--Freenome, the health technology company reinventing disease manageme... | citybizlis... |
| 01.03.2017 | Freenome Raises $65M in Series A Funding | Freenome, a San Francisco, CA-based health technology company, raised $65m in Series A funding.
The ... | finsmes.co... |
| 09.06.2016 | Liquid biopsy startup Freenome lands $5.5 million led by And... | Freenome, a year-old liquid biopsy diagnosis platform that detects the cell-free DNA sequencing of c... | techcrunch... |
| 09.06.2016 | Early-Detection Cancer Test Developer Freenome Raises $5.6M | Freenome, a Palo Alto, CA-based developer of early-detection cancer tests, raised $5.6m in seed fund... | finsmes.co... |
| - | Guardant Health study shows liquid biopsy picking up more mu... | Published results of a liquid biopsy study in lung cancer patients could lead oncologists to priorit... | medcitynew... |
| - | Report: Alphabet venture arm GV, Khosla Ventures claim top s... | Healthcare investments hit $3.8 billion in the second quarter of 2017, marking a spike in these deal... | medcitynew... |
| - | Freenome nabs $160M to advance blood-based colorectal cancer... | Investors have poured boatloads of cash into liquid biopsy companies promising that their technology... | medcitynew... |
| - | Freenome | “Home | Freenome” | fastfounde... |
| - | With new $600M fund, CRV expands into bioengineering investm... | Early stage venture capital firm CRV has closed a $600 million fund that accomplishes a couple of fi... | medcitynew... |
| - | BrightEdge joins world class investors to help accelerate ea... | SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Freenome, a biotechnology company that has pioneered t... | acsbrighte... |
